C.G. Alexopoulos

Serum lipids and lipoprotein disorders in cancer patients

C.G. Alexopoulos, B. Blatsios, Alec Avgerinos · Cancer · 1987 · 128 citations · Full text

Metabolic Syndrome, Lipid Disorder, Epidemiology +13

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

Eric Van Cutsem, David Cunningham, W.W. ten Bokkel Huinink et al. · European Journal of Cancer · 1999 · 109 citations · Full text

Health Sciences, Medicine, Pharmacology +8

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

C.G. Alexopoulos, Michael Vaslamatzis, G Hatzidimitriou · British Journal of Cancer · 1999 · 99 citations · Full text

Immunology, Hepatitis B, Pathology +16

Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.

E. Wiltshaw, S Subramarian, C.G. Alexopoulos et al. · PubMed · 1980 · 78 citations

Cancer Management, Pathology, Gynecology +16

Changes in serum lipids and lipoproteins in cancer patients during chemotherapy

C.G. Alexopoulos, Stavros Pournaras, Michael Vaslamatzis et al. · Cancer Chemotherapy and Pharmacology · 1992 · 68 citations

Lipid Analysis, Oncology, Medicine +8